Benitec Biopharma (BNTC) Non Operating Investment Income (2019 - 2023)
Benitec Biopharma (BNTC) posted Non Operating Investment Income of -$1000.0 for Q4 2023, down 200.0% sequentially from $1000.0 in Q2 2023, and up 66.67% YoY from -$600.0 in Q4 2022.
Powered by 
Analysis
Benitec Biopharma (BNTC) Non Operating Investment Income (2019 - 2023) Analysis & Trends
Benitec Biopharma has reported Non Operating Investment Income for 5 years, with the latest figure at -$1000.0 in Q4 2023.
- Quarterly Non Operating Investment Income rose 66.67% year-over-year to -$1000.0 in Q4 2023, while the trailing twelve-month figure through Dec 2024 was -$1000.0 (up 75.0% YoY) and the FY2024 annual result came in at -$1000.0, up 66.67% from the prior year.
- Non Operating Investment Income slipped to -$1000.0 in Q4 2023 per BNTC's latest filing, from $1000.0 in the prior quarter.
- Over five years, Non Operating Investment Income peaked at $19000.0 in Q2 2021 and troughed at -$23000.0 in Q4 2021.
- A 5-year average of $71.43 and a median of -$1000.0 in 2019 frame the typical range for Non Operating Investment Income.
- The sharpest annual moves came in 2021 and 2023: Non Operating Investment Income plunged 2200.0% in 2021, then jumped 200.0% in 2023.
- Over 5 years, Non Operating Investment Income stood at -$1000.0 in 2019, then changed by 0.0% to -$1000.0 in 2020, then slumped by 2200.0% to -$23000.0 in 2021, then soared by 86.96% to -$3000.0 in 2022, then soared by 66.67% to -$1000.0 in 2023.
- According to Business Quant data, Non Operating Investment Income over the past three periods registered -$1000.0, $1000.0, and -$4000.0 for Q4 2023, Q2 2023, and Q1 2023 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Benitec Biopharma | 588.88 Mn | 588.88 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | -1,000.00 |
| Jun 30, 2023 | 1,000.00 |
| Mar 31, 2023 | -4,000.00 |
| Dec 31, 2022 | -3,000.00 |
| Sep 30, 2022 | 3,000.00 |
| Jun 30, 2022 | -1,000.00 |
| Mar 31, 2022 | -5,000.00 |
| Dec 31, 2021 | -23,000.00 |
| Sep 30, 2021 | 18,000.00 |
| Jun 30, 2021 | 19,000.00 |
| Mar 31, 2021 | -2,000.00 |
| Dec 31, 2020 | -1,000.00 |
| Dec 31, 2019 | -1,000.00 |
| Sep 30, 2019 | 1,000.00 |